Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Operating Expenses: 2012-2025

Historic Operating Expenses for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $41.7 million.

  • CorMedix's Operating Expenses rose 196.90% to $41.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.5 million, marking a year-over-year increase of 68.77%. This contributed to the annual value of $62.6 million for FY2024, which is 27.94% up from last year.
  • Per CorMedix's latest filing, its Operating Expenses stood at $41.7 million for Q3 2025, which was up 127.67% from $18.3 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Operating Expenses ranged from a high of $41.7 million in Q3 2025 and a low of $5.9 million during Q2 2021.
  • Its 3-year average for Operating Expenses is $17.3 million, with a median of $15.7 million in 2024.
  • Per our database at Business Quant, CorMedix's Operating Expenses crashed by 34.11% in 2021 and then surged by 196.90% in 2025.
  • Quarterly analysis of 5 years shows CorMedix's Operating Expenses stood at $7.8 million in 2021, then climbed by 8.09% to $8.4 million in 2022, then spiked by 50.23% to $10.5 million in 2023, then skyrocketed by 34.29% to $17.1 million in 2024, then spiked by 196.90% to $41.7 million in 2025.
  • Its Operating Expenses was $41.7 million in Q3 2025, compared to $18.3 million in Q2 2025 and $17.4 million in Q1 2025.